Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTAFR | P25105 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
| ▸ | AKT1 | P31749 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18194034 | 0.89 | KDM4E (0.43) | PTAFRKDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL24903191 | 0.89 | KDM4E (0.43) | PTAFRKDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL21868751 | 0.89 | KDM4E (0.43) | PTAFRKDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL24902728 | 0.89 | KDM4E (0.43) | PTAFRKDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL20812573 | 0.89 | KDM4E (0.43) | PTAFRKDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL23154506 | 0.89 | KDM4E (0.43) | PTAFRKDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL24902912 | 0.88 | KDM4E (0.42) | PTAFRKDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL24119027 | 0.88 | KDM4E (0.42) | PTAFRKDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL24902742 | 0.88 | KDM4E (0.42) | PTAFRKDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL23154504 | 0.88 | KDM4E (0.42) | PTAFRKDM4EATML3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230006161-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-01-05 | — | — | US | disclosed |
| US-20210399234-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-12-23 | — | — | US | disclosed |
| US-10573824-B2 | Compound and organic electronic element comprising same | LG CHEM, LTD. (KR) | 2020-02-25 | — | — | US | disclosed |
| US-20180090688-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
| US-20180090688-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180090688-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | OR10J3, ETV6, BMI1 | PTAFR 4778/4885KDM4E 390/4885ATM 2315/4885 |
| US-10573824-B2 | Compound and organic electronic element comprising same | OR10J3, ETV6, BMI1 | PTAFR 4778/4885KDM4E 390/4885ATM 2315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.